...
首页> 外文期刊>Coordination chemistry reviews >Recent advances in delivery of photosensitive metal-based drugs
【24h】

Recent advances in delivery of photosensitive metal-based drugs

机译:发出光敏金属类药物的最新进展

获取原文
获取原文并翻译 | 示例
           

摘要

Metal-based drugs have drawn significant attention over the past few decades due to their advanced properties and benefits in biomedical therapeutic and diagnostic systems. Among those, phototherapy using photosensitive metal-based drugs is of particular interest to researchers since the combination of light with metallo drugs allows controlled, light-activated release of anti-disease compounds with tremendous clinical significance. Due to its promising prospectives, especially in cancer treatment, numerous drug delivery carriers, including polymer nanoparticles, solid lipid, and inorganic nanoparticles, were developed for delivering photosensitive metal-based drugs. This review presents a comprehensive overview on recent advances of the controlled delivery of photosensitive metal-based drugs. Every aspect of novel polymer-based photosensitive metal-based drug delivery systems, including their fabrication methods, mechanism of action, applications in cancer therapy, as well as the prospect of future development is discussed in detail. It can be promisingly envisioned that the future direction of drug delivery systems with photosensitive metal-based drugs will result in a new generation of clinical and translational medicines combined with the rapid progression of targeted therapy, gene therapy, and immunotherapy. (C) 2019 Elsevier B.V. All rights reserved.
机译:由于其在生物医学治疗和诊断系统中的先进性和益处,金属基药物在过去的几十年中受到了重大关注。其中,使用光敏金属的药物的光疗法对研究人员来说特别感兴趣,因为含有金属药物的光结合允许具有巨大临床意义的抗疾病化合物的控制,光活化释放。由于其有希望的前景,特别是在癌症治疗中,开发了许多药物输送载体,包括聚合物纳米颗粒,固体脂质和无机纳米颗粒,用于递送光敏金属的药物。本综述概述了近期对光敏金属类药物的近期进展的概况。新型聚合物基光敏金属的药物递送系统的各方面,包括其制备方法,作用机制,癌症治疗的应用,以及未来发展的前景。可以承诺可以设想,具有光敏金属类药物的未来药物递送系统的方向将导致新一代临床和翻译药物与靶向治疗,基因治疗和免疫疗法的快速进展相结合。 (c)2019 Elsevier B.v.保留所有权利。

著录项

  • 来源
    《Coordination chemistry reviews》 |2019年第5期|154-179|共26页
  • 作者单位

    Chinese Acad Sci Changchun Inst Appl Chem State Key Lab Polymer Phys & Chem Changchun 130022 Jilin Peoples R China|Tufts Univ Dept Biomed Engn Medford MA 02155 USA;

    China Univ Petr State Key Lab Heavy Oil Proc Beijing Key Lab Biogas Upgrading Beijing 102249 Peoples R China;

    Chinese Acad Sci Changchun Inst Appl Chem State Key Lab Polymer Phys & Chem Changchun 130022 Jilin Peoples R China;

    Chinese Acad Sci Changchun Inst Appl Chem State Key Lab Polymer Phys & Chem Changchun 130022 Jilin Peoples R China;

    Chinese Acad Sci Changchun Inst Appl Chem State Key Lab Polymer Phys & Chem Changchun 130022 Jilin Peoples R China|Univ Sci & Technol China Hefei 230026 Anhui Peoples R China;

    Chinese Acad Sci Changchun Inst Appl Chem Key Lab Polymer Ecomat Changchun 130022 Jilin Peoples R China;

    SUNY Stony Brook Dept Mat Sci & Chem Engn Stony Brook NY 11794 USA;

    West Virginia Univ Dept Chem & Biomed Engn Morgantown WV 26506 USA;

    NYU Dept Chem & Biomol Engn Brooklyn NY 11201 USA;

    Southern Med Univ Sch Pharmaceut Sci Guangdong Prov Key Lab New Drug Screening Guangzhou 510515 Guangdong Peoples R China;

    Chinese Acad Sci Changchun Inst Appl Chem Key Lab Polymer Ecomat Changchun 130022 Jilin Peoples R China;

    Univ Chinese Acad Sci Chinese Acad Sci Beijing Natl Lab Mol Sci State Key Lab Polymer Phys & Chem Inst Chem Beijing 100190 Peoples R China;

    Chinese Acad Sci Changchun Inst Appl Chem State Key Lab Polymer Phys & Chem Changchun 130022 Jilin Peoples R China;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号